Intravenous iron dextran is widely used in hemodialysis patients receiving erythropoietin (EPO) therapy because of its significant convenience in clinical practice. However, the amount of iron removed ...
In a multicenter, open-label trial with blinded end-point evaluation, we randomly assigned adults undergoing maintenance hemodialysis to receive either high-dose iron sucrose, administered ...
A randomized, controlled trial was conducted to evaluate the effects of intradialytic parenteral nutrition (IDPN) using ENEFLUID® in malnourished hemodialysis patients. While no changes were observed ...
Background A 48-year-old man with a recent diagnosis of multiple myeloma and rapidly progressive oliguric end-stage renal disease requiring hemodialysis, presented with a serum calcium concentration ...
Getting your Trinity Audio player ready... A Denver-based kidney-care provider has received a $30 million infusion from Goldman Sachs Group Inc. to fund growth that includes adding treatment centers.
Baxter International's ($BAX) sales of infusion pumps and related equipment grew moderately in the 2013 first quarter, reflecting slow growth in the company as a ...
Dialysis is a treatment that takes over your kidney functions if those organs stop doing their job. If your kidney disease becomes very severe and crosses a point where there's not enough function to ...
A Baxter Healthcare plant in Illinois failed to put in place adequate quality control practices in the manufacture of HomeChoice dialysis and iPump pain management systems, the FDA tells the company ...
Iron deficiency is common in hemodialysis patients for several reasons. These include substantial losses of blood caused by taking frequent blood samples for analysis, blood remaining in the dialysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results